KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Payables: 2009-2024

Historic Payables for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $1.4 billion.

  • Quest Diagnostics' Payables rose 10.97% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year increase of 5.99%. This contributed to the annual value of $1.4 billion for FY2024, which is 2.58% up from last year.
  • As of FY2024, Quest Diagnostics' Payables stood at $1.4 billion, which was up 2.58% from $1.4 billion recorded in FY2023.
  • Over the past 5 years, Quest Diagnostics' Payables peaked at $1.6 billion during FY2020, and registered a low of $1.4 billion during FY2023.
  • Its 3-year average for Payables is $1.4 billion, with a median of $1.4 billion in 2024.
  • Per our database at Business Quant, Quest Diagnostics' Payables spiked by 56.87% in 2020 and then decreased by 12.75% in 2022.
  • Over the past 5 years, Quest Diagnostics' Payables (Yearly) stood at $1.6 billion in 2020, then decreased by 2.02% to $1.6 billion in 2021, then fell by 12.75% to $1.4 billion in 2022, then decreased by 2.65% to $1.4 billion in 2023, then rose by 2.58% to $1.4 billion in 2024.